Risankizumab Interactions
There are 191 drugs known to interact with risankizumab, along with 4 disease interactions. Of the total drug interactions, 45 are major, 137 are moderate, and 9 are minor.
- View all 191 medications that may interact with risankizumab
- View risankizumab disease interactions (4)
Most frequently checked interactions
View interaction reports for risankizumab and the medicines listed below.
- Activated Charcoal (charcoal)
- Adalat (nifedipine)
- Allergen (antipyrine / benzocaine otic)
- Atelvia (risedronate)
- Avapro (irbesartan)
- Boniva (ibandronate)
- Brilinta (ticagrelor)
- Canasa (mesalamine)
- Carafate (sucralfate)
- Catapres (clonidine)
- Cetaphil Restoraderm Moisturizer (emollients topical)
- Chantix (varenicline)
- Children's Claritin Allergy (loratadine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Dovonex (calcipotriene topical)
- Enbrel (etanercept)
- Ethyl Alcohol (ethanol)
- Fiber Choice (inulin)
- Florastor (saccharomyces boulardii lyo)
- GenRx Tramadol (tramadol)
- Heparin Sodium (heparin)
- Lithium Carbonate ER (lithium)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Sotalol Hydrochloride AF (sotalol)
- Valproate Sodium (valproic acid)
Risankizumab disease interactions
There are 4 disease interactions with risankizumab which include:
Report options
More about risankizumab
- risankizumab consumer information
- Compare alternatives
- Reviews (66)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
